000 | 01071 a2200301 4500 | ||
---|---|---|---|
005 | 20250516193346.0 | ||
264 | 0 | _c20150217 | |
008 | 201502s 0 0 ger d | ||
022 | _a1615-6692 | ||
024 | 7 |
_a10.1007/s00059-013-4013-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCustodis, F | |
245 | 0 | 0 |
_a[Treatment of lipid disorders]. _h[electronic resource] |
260 |
_bHerz _cFeb 2014 |
||
300 |
_a119-28; quiz 129-30 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article | ||
650 | 0 | 4 |
_aCombined Modality Therapy _xmethods |
650 | 0 | 4 | _aExercise Therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aHyperlipidemias _xdiagnosis |
650 | 0 | 4 |
_aHypolipidemic Agents _xadministration & dosage |
650 | 0 | 4 | _aRisk Reduction Behavior |
650 | 0 | 4 | _aSmoking Cessation |
700 | 1 | _aLaufs, U | |
773 | 0 |
_tHerz _gvol. 39 _gno. 1 _gp. 119-28; quiz 129-30 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00059-013-4013-x _zAvailable from publisher's website |
999 |
_c23490301 _d23490301 |